Population Pharmacokinetics of Dolutegravir in HIV-Infected Pediatric Subjects

被引：0
|
作者：
Singh, Rajendra P. [1 ]
Edwards, Alena Yin [2 ]
Ruel, Theodore [3 ]
Wiznia, Andrew [4 ]
Acosta, Edward [5 ]
Hazra, Rohan [6 ]
Buchanan, Ann M. [7 ]
机构：
[1] GlaxoSmithKline, CPMS, Philadelphia, PA USA
[2] ICON Plc Ireland, Dublin, Ireland
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Univ Alabama Birmingham, Birmingham, AL USA
[6] NICHD, NIH, Bethesda, MD USA
[7] ViiV Healthcare, Res Triangle Pk, NC USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-64
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF RIBAVIRIN IN ASYMPTOMATIC HIV-INFECTED PATIENTS
    LERTORA, JJ
    REGE, AB
    FERENCZ, N
    LACOUR, JT
    ERNSTTRIANA, L
    JEFFERS, T
    GEORGE, WJ
    VANDYKE, RB
    AGRAWAL, KC
    HYSLOP, NE
    CLINICAL RESEARCH, 1990, 38 (01): : A7 - A7
  • [42] PHARMACOKINETICS OF PHOSPHORYLATED ZIDOVUDINE IN HIV-INFECTED PATIENTS
    STRETCHER, BN
    PESCE, AJ
    HURTUBISE, PE
    FRAME, PT
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 182 - 182
  • [43] Pharmacokinetics of raltegravir in the semen of HIV-infected men
    Antoniou, Tony
    Loutfy, Mona R.
    Brunetta, Jason
    Smith, Graham
    Halpenny, Roberta
    la Porte, Charles
    ANTIVIRAL THERAPY, 2014, 19 (06) : 607 - 611
  • [44] Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women
    Tran, Anna H.
    Best, Brookie M.
    Stek, Alice
    Wang, Jiajia
    Capparelli, Edmund V.
    Burchett, Sandra K.
    Kreitchmann, Regis
    Rungruengthanakit, Kittipong
    George, Kathleen
    Cressey, Tim R.
    Chakhtoura, Nahida
    Smith, Elizabeth
    Shapiro, David E.
    Mirochnick, Mark
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (03) : 289 - 296
  • [45] Population pharmacokinetic and pharmacodynamic analysis of tesamorelin in HIV-infected patients and healthy subjects
    Gonzalez-Sales, Mario
    Barriere, Olivier
    Tremblay, Pierre Olivier
    Nekka, Fahima
    Mamputu, Jean-Claude
    Boudreault, Sylvie
    Tanguay, Mario
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 (03) : 287 - 299
  • [46] Population pharmacokinetic and pharmacodynamic analysis of tesamorelin in HIV-infected patients and healthy subjects
    Mario González-Sales
    Olivier Barrière
    Pierre Olivier Tremblay
    Fahima Nekka
    Jean-Claude Mamputu
    Sylvie Boudreault
    Mario Tanguay
    Journal of Pharmacokinetics and Pharmacodynamics, 2015, 42 : 287 - 299
  • [47] Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment
    Stephen Weller
    Julie Borland
    Shuguang Chen
    Mark Johnson
    Paul Savina
    Brian Wynne
    Toshihiro Wajima
    Amanda F. Peppercorn
    Stephen C. Piscitelli
    European Journal of Clinical Pharmacology, 2014, 70 : 29 - 35
  • [48] Dolutegravir plus rilpivirine in suppressed heavily pretreated HIV-infected patients
    Diaz, A.
    Casado, J. L.
    Dronda, F.
    Gomez-Ayerbe, C.
    Vivancos, M. J.
    Banon, S.
    Quereda, C.
    Serrano, S.
    Moreno, A.
    Navas, E.
    Rodriguez, M. A.
    Perez-Elias, M. J.
    Moreno, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [49] Dolutegravir Dual Therapy as Maintenance Treatment in HIV-Infected Patients: A Review
    Boswell, Rosaleen
    Foisy, Michelle M.
    Hughes, Christine A.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (07) : 681 - 689
  • [50] Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
    Maggiolo, Franco
    Gulminetti, Roberto
    Pagnucco, Layla
    Digaetano, Margherita
    Benatti, Simone
    Valenti, Daniela
    Callegaro, Annapaola
    Ripamonti, Diego
    Mussini, Cristina
    BMC INFECTIOUS DISEASES, 2017, 17
12345